- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05383989
The UniVenture Program
UniVenture: A Partnership to Address Heavy Drinking and Other Substance Misuse on Canadian University Campuses
Study Overview
Status
Detailed Description
The UniVenture program is a wellness program designed for university students, to be tested at 5 university-based sites (Dalhousie University, St. Francis Xavier University, York University, Université de Montréal, and University of British Columbia-Okanagan), and based on an existing, successful, and internationally recognized and -utilized program called PreVenture (designed for high school students). PreVenture is a selective personality-targeted approach based on an etiologic model of substance misuse behaviors, outlined and validated by Drs. Stewart (Project Director [PD]) and Conrod (Co-Applicant [CA]). PreVenture targets personality-specific motivational pathways to substance misuse, AS, HOP, SS, and IMP, each associated with different motives for substance use, substance use profiles, and patterns of emotional distress and risk-taking. Well-controlled studies show PreVenture reduces or delays teens' binge drinking, illicit drug use, and associated emotional problems by 30-80% with effects lasting at least 2 years. While PreVenture: (a) was designed for and is effective for high school students, its efficacy in university students is untested; (b) is effective for alcohol and cannabis use, its effects on prescription drug misuse are unknown; and (c) works to reduce student distress, it is untested for preventing academic struggles and university drop out. These latter academic outcomes are of major concern to our Student Affairs partners given the current shockingly high university drop-out rates (18.7-36.9%) and strong ties of student substance misuse and distress with poorer academic outcomes. The purpose of the UniVenture study is to measure the efficacy the developmentally adapted program has on primary outcomes of (1) Reduction of alcohol-related harms in undergraduates (2) Reduction of cannabis-related harms in undergraduates (3) Changes in the student wellbeing in undergraduates. Secondary outcomes are (1) Differences in semester GPA between treatment groups. (2) Changes in scores on the undergraduates' Academic retention measure (3) Changes in scores on the undergraduates' Academic challenges measure (4) Changes in scores on the undergraduate self-regulated learning (SRL) behaviour measure and Self-efficacy beliefs for undergraduates' success measures (5) Reduction in score of hazardous drinkers in undergraduates.
Barriers to accessing evidence-based programs contribute to the ineffectiveness of campus-based substance misuse prevention. These barriers include students' time commitments, lack of available services, fear of stigma, and long wait lists which may discourage students from seeking or engaging in existing programs, leading to more severe problems before participants receive help. A distance-delivery approach involves using remote communication technologies (e.g., web-based, email, chat) to link students with a facilitator in place of face-to-face meetings. This may improve access for those with difficulties getting to services or increase confidentiality through engagement from a private location. The investigator proposes a novel randomized controlled study to test the relative effects of our personality-targeted wellness program on hazardous drinking, cannabis use, and uptake of prescription drug misuse among high-personality-risk 1st and 2nd year undergraduates and delivered in 2 formats: traditional face-to-face vs. an innovative and more accessible technology-assisted distance-delivery by well-trained and supervised program facilitators. These two active program conditions will be compared to a services-as-usual only control condition to evaluate how this program compares to what Student Affairs unit partners already do. Withholding the program from at-risk undergraduates randomized to the services-as-usual only control group might be seen as problematic; however, the program's efficacy is untested at the emerging adulthood (EA) developmental stage and in the university context. If the distance-delivered program is shown effective, control condition participants will be sent a free link to the relevant personality-matched web-based materials after the 12-month follow-up.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fakir Md Yunus
- Phone Number: 306-514-0055
- Email: fakir.yunus@dal.ca
Study Contact Backup
- Name: Jennifer E Swansburg
- Phone Number: 902-494-3793
- Email: jennifer.swansburg@dal.ca
Study Locations
-
-
British Columbia
-
Kelowna, British Columbia, Canada
- Recruiting
- University of British Columbia-Okanagan campus
-
Contact:
- Cassidy RD Wallis, MA
- Email: cassidywallis13@gmail.com
-
Contact:
- Katherine Rose, MA
- Email: katherine.rose@ubc.ca
-
-
Nova Scotia
-
Antigonish, Nova Scotia, Canada
- Recruiting
- St. Francis Xavier University
-
Contact:
- Stephanie Cooper
- Email: scooper@stfx.ca
-
Halifax, Nova Scotia, Canada
- Recruiting
- Dalhousie University
-
Contact:
- Jennifer E Swansburg
- Phone Number: 902-494-3793
- Email: jennifer.swansburg@dal.ca
-
Contact:
- Fakir Md Yunus, PhD
- Phone Number: 306-514-0055
- Email: fakir.yunus@dal.ca
-
-
Ontario
-
Toronto, Ontario, Canada
- Recruiting
- York University
-
Contact:
- Matthew Keough, PhD
- Email: keoughmt@yorku.ca
-
-
Quebec
-
Montréal, Quebec, Canada
- Recruiting
- Université de Montréal
-
Contact:
- Patricia Conrod, PhD
- Email: Patricia.conrod@umontreal.ca
-
Sub-Investigator:
- Natalie Castellanos-Ryan, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1st and 2nd year undergraduate students (either part-time or full-time enrollment)
- Age between 18- 25 years
- Have used alcohol and/or cannabis and/or any other substance in the past 3 months,
- Score at least 0.5 standard deviation (SD) above the population-specific norm on 1 of 4 personality traits on the Substance Use Risk Profile Scale (SURPS) (i) Anxiety Sensitivity (AS) (ii) Hopelessness (HOP) (iii) Sensation Seeking (SS) and (iv) Impulsive (IMP)
Exclusion Criteria:
• Unwilling to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: UniVenture- face-to-face (in-person format)
Personality-matched wellness program condition in face-to-face format (i.e., high AS student receives face-to-face AS program; high HOP student receives face-to-face HOP workshop: high SS student receives face-to-face SS workshop; high IMP student receives face-to-face IMP workshop)
|
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Hopelessness (HOP) personality traits on the Substance Use Risk Profile Scale (SURPS).
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Anxiety Sensitivity (AS) personality traits on the Substance Use Risk Profile Scale (SURPS).
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Sensation Seeking (SS) personality traits on the Substance Use Risk Profile Scale (SURPS)
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Impulsivity (IMP) personality traits on the Substance Use Risk Profile Scale (SURPS).
|
|
ACTIVE_COMPARATOR: UniVenture- online (distance-delivery format)
Personality-matched wellness program condition in distance-delivery format (i.e., high AS student receives online (distance-delivered) AS workshop; high HOP student receives online (distance-delivered) HOP workshop: high SS student receives online (distance-delivered) SS workshop; high IMP student receives online (distance-delivered) IMP workshop
|
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Hopelessness (HOP) personality traits on the Substance Use Risk Profile Scale (SURPS).
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Anxiety Sensitivity (AS) personality traits on the Substance Use Risk Profile Scale (SURPS).
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Sensation Seeking (SS) personality traits on the Substance Use Risk Profile Scale (SURPS)
Intended for those who score at least 0.5 standard deviation (SD) above the population-specific norm on Impulsivity (IMP) personality traits on the Substance Use Risk Profile Scale (SURPS).
|
|
PLACEBO_COMPARATOR: UniVenture- service as usual (control)
Services-as-usual offered by the respective university
|
It is the regular university-provided well-being services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in alcohol-related harms in undergraduates
Time Frame: Past 3 months
|
Alcohol use as a continuous measure of alcohol-related harm. The Brief-Young Adult Alcohol Consequences Questionnaire (B-YAACQ) is a 24-item scale that will be used to measure changes in the experiences of alcohol-related harms in the past 3 months. The response options include (1) Yes, in the past 3 months, (2) Yes, but not in the past 3 months (3) No. This measure will be scored as the number of adverse consequences experienced in the last three months on a continuous scale from 0-24. [Higher scores indicate greater adverse alcohol consequences] |
Past 3 months
|
|
Changes in cannabis-related harms in undergraduates
Time Frame: Past 3 months
|
Cannabis use as a continuous measure of cannabis-related harm. The Brief Marijuana Consequences Questionnaire (BMACQ) is a 21-item scale that will be used to measure changes in participants' reported experiences of cannabis-related harms in the past 3 months. The response options include (1) Yes, in the past 3 months, (2) Yes, but not in the past 3 months (3) No. This measure will be scored as the number of adverse consequences experienced in the last three months on a continuous scale from 0-21. [Higher scores indicate greater adverse cannabis consequences] |
Past 3 months
|
|
Changes in the student wellbeing in undergraduates
Time Frame: Past 3 months
|
It will be measured by the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) - which combines the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scales - as a composite measure of depression and anxiety. Response option of Generalized Anxiety Disorder (GAD-7) is (1) Not at all (2) Several days (3) More than half of the days (4) Nearly every day. Response option of Patient Health Questionnaire (PHQ-9) is (1) Not at all (2) Several days (3) Over half the days (4) Nearly every day. [Higher scores indicate higher mental wellbeing] |
Past 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in semester GPA between treatment groups.
Time Frame: Through study completion, an average of 1 year
|
Semester-wise grade point average [GPA] as a proxy of Undergraduates' academic performance (i.e., objective indices of grades). GPA data retrieved from the registrar's office at each site will be converted to a common 6-point GPA scale since different university sites use different GPA scales (%, 5-point GPA, 9-point GPA). The scale ranges from 1 to 6 where 1 indicates lower performance and 6 indicates higher performance. [Higher scores indicate higher GPA in that semester.] |
Through study completion, an average of 1 year
|
|
Changes in scores on the undergraduates' Academic retention measure
Time Frame: Through study completion, an average of 1 year
|
Measured by the 6-item self-reported Academic outcome survey: Academic experience scale. Item response options include (1) Strongly disagree (2) Disagree (3) Neither agree nor disagree (4) Agree (5) Strongly agree. A total score is derived by summing scores across the 6 items. [Higher scores indicate higher academic retention]. |
Through study completion, an average of 1 year
|
|
Changes in scores on the undergraduates' Academic challenges measure
Time Frame: Past 2 weeks
|
This is assessed with a 35-item Academic outcome survey. This composite score [Self-Regulated Learning -Challenges Scale (SRL-C)] will represent the academic challenges experienced. Item response options range from: (1) Strongly disagree to (5) Strongly agree. The composite score is comprised of five areas of academic challenges typically reported by undergraduate students: (1) Motivation (e.g., challenges initiating and sustaining engagement); (2) Goal and time management (e.g., challenges making deadlines, or managing priorities) (3) Cognitive (challenges maintaining focus, understanding course material (4) Socio-emotional (challenges adjusting to new academic expectations; balancing health and well-being); and (5) Meta-cognitive (challenges setting goals or choosing strategies). [Higher scores on the composite indicate greater levels of academic challenges being experienced by the student.] |
Past 2 weeks
|
|
Changes in scores on the undergraduate self-regulated learning (SRL) behaviour measure and Self-efficacy beliefs for undergraduates' success measures
Time Frame: Past 2 weeks
|
Two separate scales [SRL Self-Regulated Learning -Practices Scale (SRL-P) and Self-Regulated Learning -Challenges Scale (SRL-C)] will be combined and consist of 35 items from the Academic outcome survey with response options of (1) Strongly disagree (2) Disagree (3) Neutral (4) Agree (5) Strongly agree. [Higher scores indicate more proactive self-regulated learning behaviours/practices and indicate stronger belief about academic success] |
Past 2 weeks
|
|
Changes in score of hazardous drinkers in undergraduates
Time Frame: Past 3 months
|
This 3-item The Alcohol Use Disorders Identification Test Consumption screening tool (AUDIT-C) questions (composite score) capture individuals who are hazardous drinkers or who have alcohol use disorders (including alcohol abuse or dependence). It is scored on a scale of 0-12 points (each item has maximum of 4 score where 0 reflect no alcohol use). In men, a score of 4 points or more is considered positive for alcohol misuse; in women, a score of 3 points or more is considered positive. Generally, the higher the AUDIT-C score, the higher the likelihood of affecting health and safety due to individual's drinking. |
Past 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Sherry H Stewart, Dalhousie University
- Principal Investigator: Patricia Conrod, Université de Montréal
- Principal Investigator: Kara Thompson, St. Francis Xavier University
- Principal Investigator: Matthew T Keough, York University
- Principal Investigator: Marvin Krank, University of British Columbia- Okanagan
- Principal Investigator: Allyson Hadwin, University of Victoria
Publications and helpful links
General Publications
- Woicik PA, Stewart SH, Pihl RO, Conrod PJ. The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles. Addict Behav. 2009 Dec;34(12):1042-55. doi: 10.1016/j.addbeh.2009.07.001. Epub 2009 Jul 8.
- Szalavitz, M. (2016, September 29). The 4 traits that put kids at risk for addiction. The New York Times. Retrieved from https://www.nytimes.com/2016/10/04/well/family/the-4-traits-that-put-kids-at- risk-for-addiction.html
- Nair, R. (2017, January 22). Vernon, B. C. schools to pilot program that identifies addiction personality traits. CBC News. Retrieved from https://www.cbc.ca/news/canada/british-columbia/vernon-b- c-schools-to-pilot-program-thatidentifies-addiction-personality-traits-1.3942792
- UNESCO, UNODC, & WHO. (2017). Education sector responses to the use of alcohol, tobacco and drugs. In the UNESCO series Good Policy and Practice in Health Education. Retrieved from http://www.who.int/substance_abuse/activities/education_sector/en/
- U.S. Department of Health and Human Services. (2016, November). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: Author. Retrieved from https://houstonrecoverycenter.org/wp-content/uploads/2018/02/United-States-Surgeon- General-2016-Facing-Addiction-in-America.pdf
- Conrod PJ, Stewart SH, Comeau N, Maclean AM. Efficacy of cognitive-behavioral interventions targeting personality risk factors for youth alcohol misuse. J Clin Child Adolesc Psychol. 2006 Dec;35(4):550-63. doi: 10.1207/s15374424jccp3504_6.
- Castellanos-Ryan, N., & Conrod, P. J. (2012). Personality and substance misuse: Evidence for a four-factor model of vulnerability. In Verster, J. C., Brady, K., Galanter, M., & Conrod, P. J. (Eds.), Drug abuse and addiction in medical illness: Causes, consequences and treatment (pp. 47-62). New York: Springer.
- Stewart, S. H., Grant, V. V., Mackie, C. J., & Conrod, P. J. (2016). Comorbidity of anxiety and depression with substance use disorders. In K. Sher (Ed.), The Oxford Handbook of Substance Use Disorders. New York: Oxford University Press.
- Conrod PJ, Pihl RO, Stewart SH, Dongier M. Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychol Addict Behav. 2000 Sep;14(3):243-56. doi: 10.1037//0893-164x.14.3.243.
- Conrod PJ, Castellanos N, Mackie C. Personality-targeted interventions delay the growth of adolescent drinking and binge drinking. J Child Psychol Psychiatry. 2008 Feb;49(2):181-90. doi: 10.1111/j.1469-7610.2007.01826.x.
- Conrod PJ, Castellanos-Ryan N, Strang J. Brief, personality-targeted coping skills interventions and survival as a non-drug user over a 2-year period during adolescence. Arch Gen Psychiatry. 2010 Jan;67(1):85-93. doi: 10.1001/archgenpsychiatry.2009.173.
- O'Leary-Barrett M, Mackie CJ, Castellanos-Ryan N, Al-Khudhairy N, Conrod PJ. Personality-targeted interventions delay uptake of drinking and decrease risk of alcohol-related problems when delivered by teachers. J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):954-963.e1. doi: 10.1016/j.jaac.2010.04.011. Epub 2010 Jul 31.
- Castellanos, N., & Conrod, P. J. (2006). Brief interventions targeting personality risk factors for adolescent substance misuse reduce depression, panic, and risk-taking behaviors. Journal of Mental Health, 15, 645-658.
- Mahu IT, Doucet C, O'Leary-Barrett M, Conrod PJ. Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of the adventure trial on cannabis use: a cluster-randomized controlled trial. Addiction. 2015 Oct;110(10):1625-33. doi: 10.1111/add.12991. Epub 2015 Jul 14.
- MacLean's magazine (January 8, 2018). Canadian universities with the highest (and lowest) graduation rates. Retrieved from https://www.macleans.ca/education/canadian-universities-with-the- highest-and-lowest-graduation-rates/
- Thombs DL, Olds RS, Bondy SJ, Winchell J, Baliunas D, Rehm J. Undergraduate drinking and academic performance: a prospective investigation with objective measures. J Stud Alcohol Drugs. 2009 Sep;70(5):776-85. doi: 10.15288/jsad.2009.70.776.
- Dyson R, Renk K. Freshmen adaptation to university life: depressive symptoms, stress, and coping. J Clin Psychol. 2006 Oct;62(10):1231-44. doi: 10.1002/jclp.20295.
- Olthuis, J. V., Watt, M. C., & Stewart, S. H. (2013). Increasing access to evidence-based interventions: The role of technology. Psynopsis, Summer.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-5689
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hopelessness
-
Lancashire Care NHS Foundation TrustUnknownSelf Harm | Hopelessness | Suicidal IdealtionUnited Kingdom
-
Saglik Bilimleri UniversitesiCompletedMotivation | Hopelessness | Optimism | Life SatisfactionTurkey
-
Paracelsus Medical UniversityCompleted
-
Universidad de los Andes, ChileUniversity of Talca; Fundación Crecer y SanarCompletedDepression | Anxiety | Suicidal Ideation | HopelessnessChile
-
Necmettin Erbakan UniversityCompletedDEPRESSION | ANXIETY | STRESS | HOPELESSNESS | MİNDFULNESSTurkey (Türkiye)
-
Shannon E. Sauer-ZavalaCompletedSuicidal Ideation | Hopelessness | Wish to Live | Wish to DieUnited States
-
Kocaeli Sağlık ve Teknoloji ÜniversitesiKafkas UniversityCompletedSleep Disturbance | Aging | HopelessnessTurkey (Türkiye)
-
The Cleveland ClinicMQ Mental Health ResearchNot yet recruitingSuicidal Ideation | Suicidal Behavior | Hopelessness | Suicide Attempt | Depression / Major Depressive Disorder | NeurobiologicalUnited States
-
Lisa BrennerMilitary Suicide Research ConsortiumCompletedSuicide | Traumatic Brain Injury | HopelessnessUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)CompletedCovid19 | Physical Activity | Ischemic Heart Disease | Motivation | Social Support | HopelessnessUnited States
Clinical Trials on UniVenture Hopelessness manual
-
Dordt UniversityUniversity of Illinois at Chicago; Avera McKennan Hospital & University Health... and other collaboratorsCompletedCardiac Disease | Mental Health IssueUnited States
-
Wen-Shiou PanCompletedHeart Failure | Stroke | Pulmonary Disease, Chronic Obstructive | Kidney Failure, Chronic | Alzheimer Disease, Late Onset | Kidney Failure, Acute | Cystic Fibrosis Pulmonary Exacerbation | Chronic Liver Disease and CirrhosisTaiwan
-
Investigación en Hemofilia y FisioterapiaCompleted
-
Josue Fernandez CarneroUniversidad Autonoma de MadridCompletedCervicalgia | Neck Pains | Posterior Cervical Pains | Posterior Neck Pain
-
Indonesia UniversityCompletedHead and Neck NeoplasmsIndonesia
-
Alexander AchalandabasoCompletedChronic Pain | Neck PainSpain
-
University of La LagunaActive, not recruiting
-
Hacettepe UniversityCompletedHealth Young IndividualsTurkey
-
William Beaumont HospitalsTerminatedPregnancy | Cesarean DeliveryUnited States